Recalls / —
—#65373
Product
Abbott AxSYM AUSAB Reagent Pack, List No: 3C74-20, 100 tests, an in-vitro test for Antibody to Hepatitis B Surface Antigen (Anti-HBs); Abbott Laboratories, Abbott Park, IL 60064
- FDA product code
- LOM — Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
- Device class
- Class 2
- Medical specialty
- Microbiology
- PMA numbers
- P060003
- Affected lot / code info
- Lot Numbers: 49535M100 and 55451M200
Why it was recalled
Incorrect results: Reagents in these lots were manufactured with an incorrect ratio of 2 key components, which could result in both false reactive and false nonreactive specimens.
Root cause (FDA determination)
Process change control
Action the firm took
Abbott sent a Product Recall letter, dated 10/01/07, to all AxSYM AUSAB customers that received the affected lots of product, informing them of the manufacturing error that resulted in both false reactive and false nonreactive specimens. The letter provided the assay bias for both lots. The accounts were requested to examine their inventory for the affected lots; destroy any packs found; record the number of packs destroyed on the Customer Reply Form; and fax the completed form back to Abbott at 1-800-777-0051 prior to 10/12/07. They were also requested to evaluate patient results generated with these lots in alignment with the information provided in the letter to determine if additional action is necessary. They were requested to forward a copy of the letter to any laboratory to whom they may have forwarded the lots; and to retain a copy of the letter for their records. Any questions were directed to Abbott Customer Support at 1-877-4ABBOTT.
Recalling firm
- Firm
- Abbott Laboratories
- Address
- 100 Abbott Park Rd, Abbott Park, Illinois 60064-3502
Distribution
- Distribution pattern
- Nationwide Distribution, including Puerto Rico.
Timeline
- Recall initiated
- 2007-10-01
- Posted by FDA
- 2008-01-24
- Terminated
- 2008-05-09
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #65373. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.